Yves Benoit
Overview
Explore the profile of Yves Benoit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Musoro J, Sleurs C, Rowsell A, Suciu S, Kicinski M, Chantziara S, et al.
Pediatr Blood Cancer
. 2024 Nov;
72(2):e31446.
PMID: 39616416
Purpose: Survivors of childhood cancer can suffer from long-term sequelae or decline in quality of life (QoL), for which careful and standardized selection of outcome measures become more important. This...
2.
de Ville de Goyet M, Kicinski M, Suciu S, Vandecruys E, Uyttebroeck A, Ferster A, et al.
Discov Oncol
. 2024 Jan;
15(1):20.
PMID: 38285235
Survival after childhood acute lymphoblastic leukemia (ALL) has increased over the last 40 years with an overall survival above 90%. Survivors may experience neurological late effects secondary to chemotherapy and...
3.
Chantziara S, Musoro J, Rowsell A, Sleurs C, Coens C, Pe M, et al.
Psychooncology
. 2022 Oct;
31(12):2159-2168.
PMID: 36307941
Objective: Improved treatment landscape has led to better outcomes for paediatric acute lymphoblastic leukemia (ALL) survivors. As the number of survivors increase, we need to elucidate the long-term quality of...
4.
Barbati M, Kicinski M, Suciu S, Mazingue F, Vandecruys E, Plat G, et al.
Eur J Cancer Care (Engl)
. 2022 Oct;
31(6):e13755.
PMID: 36284405
Objective: The objective of this study is to evaluate the socio-economic outcomes of survivors of childhood acute lymphoblastic leukaemia (ALL). Methods: Childhood ALL adult survivors, enrolled in EORTC trials between...
5.
Sleurs C, Musoro J, Rowsell A, Kicinski M, Suciu S, Chantziara S, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008314
Background: due to increasing survival rates in childhood acute lymphoblastic leukemia (ALL), the number of survivors has been expanding. A significant proportion of these survivors can experience long-term emotional and...
6.
Rossi G, Kicinski M, Suciu S, Vandecruys E, Plat G, Uyttebroeck A, et al.
Hum Reprod
. 2021 Nov;
37(1):44-53.
PMID: 34788455
Study Question: What are the fertility outcomes of male and female childhood acute lymphoblastic leukaemia (ALL) long-term survivors? Summary Answer: We observed similar fertility outcomes in both male and female...
7.
Mondelaers V, Ferster A, Uyttebroeck A, Brichard B, Van Der Werff Ten Bosch J, Norga K, et al.
Br J Haematol
. 2020 Feb;
190(1):105-114.
PMID: 32057100
Asparaginase (ASNase) is an important anti-leukaemic drug in the treatment of childhood acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL). A substantial proportion of patients develop hypersensitivity reactions with anti-ASNase...
8.
Piette C, Suciu S, Bertrand Y, Uyttebroeck A, Vandecruys E, Plat G, et al.
Br J Haematol
. 2019 Dec;
189(2):351-362.
PMID: 31837008
We investigated the long-term outcome, the incidence of second neoplasms (SN) and the rate of late adverse effects (LAE) in children with central nervous system (CNS) negative medium/high-risk de novo...
9.
Clement O, Dewachter P, Mouton-Faivre C, Nevoret C, Guilloux L, Bloch Morot E, et al.
EClinicalMedicine
. 2019 Jun;
1:51-61.
PMID: 31193689
Background: Iodinated and gadolinium-based contrast media (ICM; GBCM) induce immediate hypersensitivity (IH) reactions. Differentiating allergic from non-allergic IH is crucial; allergy contraindicates the culprit agent for life. We studied frequency...
10.
Paes G, Navarro D, Benoit Y, Blanquet S, Chabbert B, Chaussepied B, et al.
Biotechnol Biofuels
. 2019 Apr;
12:76.
PMID: 30976326
Background: Lignocellulose biomass is known as a recalcitrant material towards enzymatic hydrolysis, increasing the process cost in biorefinery. In nature, filamentous fungi naturally degrade lignocellulose, using an arsenal of hydrolytic...